Authors:
ROSENBLUM MG
MACEY D
PODOLOFF D
KASI L
BAYOUTH J
CUNNINGHAM J
BHADKAMKAR V
RIEGER P
THOMPSON LB
CHEUNG L
PINSKY C
SHARKEY R
MURRAY JL
Citation: Mg. Rosenblum et al., A PHASE-I PHARMACOKINETIC, TOXICITY AND DOSIMETRY STUDY OF I-131-LABELED IMMU-4 F(AB')2 IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Antibody immunoconjugates, and radiopharmaceuticals, 6(4), 1993, pp. 239-255